羊水细胞DNA分析是先天性肾上腺皮质增生症21-羟化酶缺陷的产前诊断的可靠方法。
DNA analysis of amniocytes was a feasible method for the prenatal diagnosis of congenital adrenal hyperplasia with 21-hydroxylase deficiency.
方法总结15例肾上腺性征综合征患者的临床资料，其中先天性肾上腺皮质增生13例，肾上腺皮质癌2例。
Methods The clinical data of 15 patients were summarized including 13 cases of congenital adrenal hyperplasia, and 2 cases of adrenocortical carcinoma.
治疗一些类型的先天性肾上腺增生性肥大能够运用诸如羊水诊断或绒毛膜取样的产前检查被发现。
Treatment Some forms of CAH can be detected in prenatal tests like amniocentesis or villus sampling.
目的开展新生儿先天性肾上腺皮质增生症筛查，降低残疾儿童的发生率，提高人口素质。
Objective to develop the neonatal screening for congenital adrenal hyperplasia in order to prevent children from congenital disability and improve the aristogenesis in our country.
治疗一些类型的先天性肾上腺增生性肥大能够运用诸如羊水诊断或绒毛膜取样的产前检查被发现。
Treatment Some forms of CAH can be detected in prenatal tests like amniocentesis or chorionic villus sampling.
结论羊水细胞DNA分析是先天性肾上腺皮质增生症2 1羟化酶缺陷的产前诊断的可靠方法。
Conclusion DNA analysis of amniocytes was a feasible method for the prenatal diagnosis of congenital adrenal hyperplasia with 21-hydroxylase deficiency.
结论羊水细胞DNA分析是先天性肾上腺皮质增生症2 1羟化酶缺陷的产前诊断的可靠方法。
Conclusion DNA analysis of amniocytes was a feasible method for the prenatal diagnosis of congenital adrenal hyperplasia with 21-hydroxylase deficiency.
应用推荐